Cantellano OM, Morales MG, Lamm WL, Viveros EJM, Andrade PD, Fernández CA, Vázquez OL, Recinos G, Pacheco GC, Calderón FF

Language: Spanish
References: 14
Page: 315-320
PDF size: 248.35 Kb.

ABSTRACT

The urothelial bladder cancer is the second most frequent malignant tumor in the urinary tract. The majority they are superficial and 10-20% of the cases are invasive to bladder muscle. Presentation in a bladder diverticulum is rare, with an approximate incidence of 0.8% of the cases brought in the literature. We report a case of a 62 years old masculine patient who developed a high grade urothelial tumor in a bladder diverticulum, which was handled initially with transurethral resection and a single dose 40 mg of mitomicin C postoperative. Continuing his handling with partial cystectomy, with diagnosis high grade urothelial cancer with focal invasion of bladder wall, by what it received adjuvant chemotherapy (gemcitabin + carboplatin) and radiotherapy, with suitable evolution.

REFERENCES

1. Urinary bladder, in AJCC Cancer staging manual, I.D. Fleming et al. Lippincott-Raven: Philadelphia. 1997:241-243.

2. Manoharan M, Soloway MS. Optimal management of the T1G3 bladder cancer. Urol Clin North Am. 2005;32(2):133-45.

3. M.J. Droller. Primary care update on kidney and bladder cancer: a urologic perspective. Med Clin North Am. 2004;88(2):309-28.

4. Golijanin D, Yossepowitch O, Beck SD, Sogani P, Dalbagni G. Cancer in a bladder diverticulum: Presentation and treatment outcome. J Urol. 2003;70:1761-64.

5. Chang SS, Cookson MS. Radical cystectomy for bladder cancer: The case for early intervention. Urol Clin North Am. 2005;32:147-55.

6. Brown AL JR, Zietman AL, Shipley WU, Kaufman et al. Organ preserving approach to muscle invading Transitional cell cancer of bladder. Hematol Oncol Clin North Am. 2001;15(2):354-58.

7. Holzbeierlein JM, Lopez-Corona E, Bochner BH, Herr HW, Donat SM, Russo P, Dalbagni G, Sogani PC. Partial cystectomy: a contemporary review. Of the Sloan Kettering Cancer Experience and recommendations. J Urol. 2004;172:878-81.

8. Stein JP, Skinner DG. Role of lymphadenectomy in high-grade invasive bladder cancer. Urol Clin of North Am. 2005;32(2):187-97.

9. Laufer M. Transurethral resection and partial cystectomy for invasive bladder cancer. Semin Urol Oncol. 2000;18:296-9.

10. Osterlinck, Lobel et al. EAU. Bladder Cancer Guidelines, 2001.

11. Herr HW. Surgical factors in the treatment of superficial and invasive bladder cancer. Urol Clin North Am. 2005;32(2):157-64.

12. Kassouf W, Swanson D, Kamat AM, Leibovici D, Siefker- Radtke A, Munsell MF, Grossman HB, Dinney CP. Partial cystectomy for muscle invasive urothelial carcinoma of the bladder: a contemporary review of the M. D. Anderson Cancer Center experience. J Urol. 2006;175:2058-62.

13. Grossman HB, Natale RB, Tangen CM, Speights VO, Vogelzang NJ, Trump DL. Neoadjuvant chemotherapy lus cystectomy compared with cystectomy alone for locally advanced bladder cancer. N Engl J Med. 2003;349(9):859-66.

14. Shipley WU, Kaufman DS, Zehr E, Heney NM, Lane SC, Thakral HK, Althausen AF, Zietman AL. Selective bladder preservation by combined modality protocol treatment: long-term outcomes of 190 patients with invasive bladder cancer. Urology. 2002; 60:62-7.